Maxim Turns Cautious on Reviva Pharmaceuticals Holdings, Inc. (RVPH) Despite Phase 3 Progress Plans [Yahoo! Finance]
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Company Research
Source: Yahoo! Finance
TheFly reported on April 9 that Maxim Group downgraded RVPH from Buy to Hold. The firm pointed to ongoing weakness in the share price following the company's one-for-20 reverse stock split completed on March 9. It noted that although recent funding may help advance a second Phase 3 study of brilaroxazine, additional capital will still be required. With the stock trading below the $1.00 NASDAQ compliance level, the analyst also highlighted heightened delisting risk alongside continued financing concerns as key factors behind the downgrade. Earlier on March 30, Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) reported its full-year 2025 financial results along with key business and development updates. The company posted a net loss of approximately $19.9 million, or $5.48 per share, compared with a $29.9 million loss in 2024. Cash and cash equivalents totaled about $14.4 million as of December 31, 2025. Maxim Turns Cautious on Reviva Pharmaceuticals Holdings, Inc. (RVPH) Despite
Show less
Read more
Impact Snapshot
Event Time:
RVPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVPH alerts
High impacting Reviva Pharmaceuticals Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
RVPH
News
- Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric IndicationsGlobeNewswire
- Reviva Announces Letter to ShareholdersGlobeNewswire
- Reviva Pharmaceuticals (RVPH) had its "hold" rating reaffirmed by Maxim Group.MarketBeat
- Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Reviva Reports Full Year 2025 Financial Results and Recent Business HighlightsGlobeNewswire
RVPH
Earnings
- 3/30/26 - Miss
RVPH
Sec Filings
- 4/15/26 - Form 8-K
- 3/30/26 - Form SCHEDULE
- 3/30/26 - Form S-8
- RVPH's page on the SEC website